This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Will Dillard's (DDS) Continue Its Earnings Beat Streak in Q3?
by Zacks Equity Research
Dillard's (DDS) Q3 earnings are expected to have benefited from continued consumer demand, stringent cost control and inventory management efforts.
Dillard's (DDS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Dillard's (DDS) closed the most recent trading day at $231.14, moving +1.76% from the previous trading session.
Dillard's (DDS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Dillard's (DDS) closed at $221.76 in the latest trading session, marking a +0.38% move from the prior day.
Dillard's (DDS) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Dillard's (DDS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Dillard's (DDS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Dillard's (DDS) closed at $202.79 in the latest trading session, marking a +0.15% move from the prior day.
Here is Why Growth Investors Should Buy Dillard's (DDS) Now
by Zacks Equity Research
Dillard's (DDS) possesses solid growth attributes, which could help it handily outperform the market.
Is Dillard's (DDS) Stock Outpacing Its Retail-Wholesale Peers This Year?
by Zacks Equity Research
Is (DDS) Outperforming Other Retail-Wholesale Stocks This Year?
Dillard's (DDS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Dillard's (DDS) closed at $200.37 in the latest trading session, marking a -1.03% move from the prior day.
Top Ranked Growth Stocks to Buy for September 29th
by Zacks Equity Research
GIL, CC, DDS, and TGLS made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 29, 2021.
Is Dillard's (DDS) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Dillard's (DDS) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does Dillard's (DDS) have what it takes to be a top stock pick for momentum investors? Let's find out.
Dillard's (DDS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Dillard's (DDS) closed the most recent trading day at $210.06, moving +0.03% from the previous trading session.
Tap These 4 Stocks With Amazing Interest Coverage Ratio
by Sumit Singh
A company that is capable of generating earnings well above its interest expense can withstand financial hardship. Companies such as Herc (HRI), Dillard's (DDS), AGCO Corporation (AGCO) and Hibbett (HIBB) are sound enough to meet financial obligations.
Dillard's (DDS) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Dillard's (DDS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Is Dillard's (DDS) a Solid Growth Stock? 3 Reasons to Think " Yes "
by Zacks Equity Research
Dillard's (DDS) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Dillard's (DDS) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Dillard's (DDS) closed at $199.93 in the latest trading session, marking a -1.29% move from the prior day.
Has Dillards (DDS) Outpaced Other Retail-Wholesale Stocks This Year?
by Zacks Equity Research
Is (DDS) Outperforming Other Retail-Wholesale Stocks This Year?
Is Vident Core U.S. Equity ETF (VUSE) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for VUSE
Add These 4 Stocks With Remarkable Interest Coverage Ratio
by Sumit Singh
A company that is capable of generating earnings well above its interest expense can withstand financial hardship. Herc Holdings (HRI), Dillard's (DDS), CBRE Group (CBRE) and The Interpublic Group of Companies (IPG) are strong enough to meet financial obligations.
Is Dillard's (DDS) a Solid Growth Stock? 3 Reasons to Think " Yes "
by Zacks Equity Research
Dillard's (DDS) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Dillard's (DDS) Is Up 0.44% in One Week: What You Should Know
by Zacks Equity Research
Does Dillard's (DDS) have what it takes to be a top stock pick for momentum investors? Let's find out.
Kohl's (KSS) Looks Solid on Strategic Framework, Partnerships
by Zacks Equity Research
Kohl's (KSS) has been benefiting from its strategic framework. The company remains encouraged about its traffic, with customers returning to stores.
Top Ranked Momentum Stocks to Buy for September 2nd
by Zacks Equity Research
M, SONO, DDS, and KSS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 2, 2021
Dillard's (DDS) Just Overtook the 20-Day Moving Average
by Zacks Equity Research
Is it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average?
Should Value Investors Buy Dillard's (DDS) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.